Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12109911rdf:typepubmed:Citationlld:pubmed
pubmed-article:12109911lifeskim:mentionsumls-concept:C0003289lld:lifeskim
pubmed-article:12109911lifeskim:mentionsumls-concept:C0025912lld:lifeskim
pubmed-article:12109911lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:12109911lifeskim:mentionsumls-concept:C0049506lld:lifeskim
pubmed-article:12109911lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:12109911lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:12109911lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:12109911lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:12109911lifeskim:mentionsumls-concept:C0599473lld:lifeskim
pubmed-article:12109911pubmed:issue15lld:pubmed
pubmed-article:12109911pubmed:dateCreated2002-7-11lld:pubmed
pubmed-article:12109911pubmed:abstractTextThe synthesis and resolution of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin (6-methoxymianserin, 6) are described. Furthermore, the in vitro and in vivo effects of 6 and its enantiomers are presented. 6 displayed high affinity for the 5-HT2A/2C receptors, only moderate affinity for the adrenoceptors, and no affinity for the NA reuptake site. Surprisingly, 6 also showed moderate to high affinity for the dopamine D2 receptor, an effect that resides in the (R)-(-)-enantiomer.lld:pubmed
pubmed-article:12109911pubmed:languageenglld:pubmed
pubmed-article:12109911pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:citationSubsetIMlld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109911pubmed:statusMEDLINElld:pubmed
pubmed-article:12109911pubmed:monthJullld:pubmed
pubmed-article:12109911pubmed:issn0022-2623lld:pubmed
pubmed-article:12109911pubmed:authorpubmed-author:CremersThomas...lld:pubmed
pubmed-article:12109911pubmed:authorpubmed-author:ArntJørnJlld:pubmed
pubmed-article:12109911pubmed:authorpubmed-author:WikströmHåkan...lld:pubmed
pubmed-article:12109911pubmed:authorpubmed-author:Mensonides-Ha...lld:pubmed
pubmed-article:12109911pubmed:authorpubmed-author:MoltzenEjner...lld:pubmed
pubmed-article:12109911pubmed:issnTypePrintlld:pubmed
pubmed-article:12109911pubmed:day18lld:pubmed
pubmed-article:12109911pubmed:volume45lld:pubmed
pubmed-article:12109911pubmed:ownerNLMlld:pubmed
pubmed-article:12109911pubmed:authorsCompleteYlld:pubmed
pubmed-article:12109911pubmed:pagination3280-5lld:pubmed
pubmed-article:12109911pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:meshHeadingpubmed-meshheading:12109911...lld:pubmed
pubmed-article:12109911pubmed:year2002lld:pubmed
pubmed-article:12109911pubmed:articleTitleSynthesis and pharmacological testing of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin and its enantiomers in comparison with the two antidepressants mianserin and mirtazapine.lld:pubmed
pubmed-article:12109911pubmed:affiliationDepartment of Medicinal Chemistry, University Center for Pharmacy, University of Groningen, A. Deusinglaan 1, NL-9713 AV, Groningen, The Netherlands. h.v.wikstrom@farm.rug.nllld:pubmed
pubmed-article:12109911pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12109911pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12109911pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:12109911lld:chembl